Bronchoscopic intratumoral injections of cisplatin and endostar as concomitants of standard chemotherapy to treat malignant central airway obstruction
Conclusions
We have shown that the intratumoral injection of cytotoxic cisplatin plus anti-angiogenic Endostar is an effective and safe adjuvant therapeutic option to treat malignant CAO in clinical practice. This time-staggered local and systemic treatment combination improves quality of life and clinical parameters, thus may provide a feasible therapeutic option for symptomatic CAO.
Source: Postgraduate Medical Journal - Category: General Medicine Authors: Jiang, W., Yang, X., Wang, X., Li, Y., Yang, X., Wang, N., Yin, B. Tags: Original research Source Type: research
More News: Bronchoscopy | Cancer | Cancer & Oncology | Chemotherapy | General Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Palliative | PET Scan | Study